Seeking Alpha

Jason Hart II's  Instablog

Jason Hart II
2 Followers
20 Following
Send Message
Analyst/Venture Capital
  • Rexahn poised to explode within 90 days 0 comments
    Jan 20, 2011 6:31 PM | about stocks: RNN
    Today, Rexahn Pharmaceuticals announced that Israel-based Teva Pharmaceuticals have optioned 2,334,515 shares of Rexahn’s common stock in a private offering for $3.95 million, or $1.692 per share. Rexahn is a clinical stage drug development firm with 3 major drug candidates; Serdaxin, Zoraxel, and Archexin. Clinical trial data is expected in the next 60 days, and with numerous recent advancements in late 2010, Q1 should be a tremendous boost for Rexahns stock which closed today (1/20/11) at $1.34 up 9.84%. 

    Disclosure: I am long RNN.
    Stocks: RNN
Back To Jason Hart II's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Full index of posts »
Latest Followers

StockTalks

  • RNN = huge potential
    Sep 30, 2010
More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.